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DEFICIENCY OF INDUCIBLE AND ENDOTHELIAL NITRIC OXIDE SYNTHASE RESULTS
healing, but until now it is not known if disturbances in these mechanisms play a role in nonunion and delayed union development. In this study, we explored the role of endothelial and inducible NOS deficiency in a delayed union model in mice.
Materials and methods: A 0.45 mm femur osteotomy with periosteal cauterization followed by plate-screw osteosynthesis was performed in the left leg of 20-24 week old wild type, Nos2 -/and Nos3 -/mice. Contralateral unfractured legs were used as a control. Callus volume was measured using micro-computed tomography (µCT) after 28 and 42 days of fracture healing. Immuno histochemical myeloperoxidase (MPO) staining was performed on paraffin embedded sections to assess neutrophil influx in callus tissue and surrounding proximal and distal marrow cavities of the femur. After 7 and 28 days of fracture healing, femurs were collected for amino acid and RNA analysis to study arginine-NO metabolism.
Results: With µCT, delayed union was observed in wild type animals, whereas in both Nos2 -/and Nos3 -/mice nonunion development was evident. Both knock-out strains also showed a significantly increased influx of MPO when compared with wild type mice. Concentrations of amino acids and expression of enzymes related to the arginine-NO metabolism were aberrant in NOS deficient mice when compared to contralateral control femurs and wild type samples.
Discussion and conclusion:
In the present study we show for the first time that the absence of nitric oxide synthases results in a disturbed arginine-NO metabolism and inadequate fracture healing with the transition of delayed union into a nonunion in mice after a femur osteotomy.
Based on these data we suggest that the arginine-NO metabolism may play a role in the prevention of delayed unions and nonunions.
INTRODUCTION
Normal fracture healing is a process of partially overlapping phases of inflammation, callus formation and bone remodeling in which there is an interplay between various cells, growth factors and extracellular matrix [1] . However, five to ten percent of all patients experience difficulties during the healing process [2] resulting in delayed union or nonunion of the fracture, indicated by persisting fracture lines and presence of a hypertrophic or atrophic callus [3] .
Malnutrition, drug therapy, inadequate stabilization of the fracture and/or inadequate blood supply (i.e. periosteal injury) contribute to nonunion development [4, 5] .
Adequate production of NO (nitric oxide), a free radical produced during the conversion of arginine into citrulline by nitric oxide synthases (NOSs) stimulates bone cells to regulate bone remodeling and influences vascular reactivity [6] [7] [8] . Furthermore, NO is suggested to stimulate polyamine production through the formation of ornithine, as precursors of collagen synthesis [9, 10] . An intricate interplay exists between the substrate availability of arginine and citrulline and the NOS enzyme complex ( Figure 1 ). Disturbances in arginine and citrulline have already been associated with an impaired fracture healing resulting in nonunion in humans [11] . However, the pathogenesis has not been elicited yet.
In vivo studies in rats showed the presence and localization of NOS isoforms in callus samples after creation of a femoral fracture. mRNA and protein activity of inducible NOS (iNOS or NOS2) was present during the first phase of fracture repair and was mainly localized within the intramembranous region along the edge of the periosteal callus. The constitutive and calcium dependent endothelial (eNOS or NOS3) and neuronal NOS (nNOS or NOS1) were found in later stages of fracture healing and mainly in cells lining blood vessels and in the fibrochondral region between fibrous tissue and cartilage respectively [12] [13] [14] .
We hypothesized that low amounts of NO and disturbances in arginine substrate metabolism due to an absence of either the Nos2 or Nos3 gene will inhibit callus formation and increase the risk of nonunion. Therefore, we studied the formation of callus and the arginine metabolism after a femur osteotomy with periosteal cauterization in a mouse model of delayed union.
2.

MATERIALS AND METHODS
Animals and surgical procedure
In this study, skeletally mature, 20 to 24 week old specific pathogen free (SPF), female C57Bl6/J (RCC Switzerland) and Nos2 -/and Nos3 -/-, both backcrossed more than 10 generation into the C57Bl6/J background, with constructs previously described by Laubach et al [15] and Shesely et al [16] and a lateral skin incision starting at the base of the tail towards the left knee was made. By blunt dissection between the quadriceps and biceps femoris muscles, the femur was exposed and a 1 mm segment of periosteum was cauterized circumferentially during 0.5 seconds. The soft tissue was protected by a Teflon foil during cauterization. Thereafter, an internal plate [17] (7x1.5x0.7 mm, MouseFix, RISystems Davos, Switzerland) was placed on the femur and after predrilling with a 0.33 mm drill bit the plate was fixed with four angular stable MouseFix screws (2.0 mm in length). Following fixation, a 0.45 mm mid-diaphyseal femoral gap osteotomy was performed with a Gigli wire saw in the center of the cauterized segment. Each screw was untightened by half a turn to induce secondary fracture healing [18] . Fascia and skin were closed in routine fashion Vicryl Rapide, Ethicon and Proline, Ethicon, Belgium). At the end of surgery, plate placement and fixation was confirmed radiographically. In the following 48 hours, mice received 0.1 mg/kg s.c.
buprenorphine every 10 -14 hours and for the first 5 days postoperatively 8 mg paracetamol per os/mouse/day was given through the drinking water (Dafalgan, Upsamedica, Switzerland).
Mice were sacrificed using CO 2 following different periods of fracture healing (7, 28 and 42 days after osteotomy). The veterinary welfare and ethics committee of the Canton of Graubünden (Switzerland) approved the experimental set-up and procedures of this study (permit number GR 23/2006).
Amino acid measurements
To determine arginine, citrulline and ornithine concentrations, blood was collected post mortem in heparinized tubes on ice for amino acid measurements and centrifuged immediately (4 ºC, 15 min at 8,500 g) to obtain plasma. For amino acid analysis, plasma was deproteinized using acetonitrile (ratio plasma : acetonitrile 1 : 2), vortexed and stored until further analysis at -80 ºC.
Tissue samples for amino acid measurements were snap frozen in liquid nitrogen directly after harvesting. Before analysis, frozen homogenized tissue samples were added to 0.1 g of glass beads (1.0 mm diameter) in 250 μl of 5% sulfosalicylic acid for deproteinization, beaten for 30 seconds at maximum speed with mini-beadbeater (BioSpec Products, Bartlesville, Oklahoma, USA) and stored at -80 ºC until further analysis. The contralateral right femurs of the mice were used as unfractured control bones. Plasma and tissue amino acid concentrations were measured by HPLC as previously described [19] .
The arginine availability in plasma and callus tissue was calculated as [arginine] / ([ornithine] + [lysine]
). This is based on the uptake of arginine, ornithine and lysine in cells via the y + transport system [20, 21] .
Immuno histochemistry
Following euthanasia, internal fixators were removed from the femurs and samples were fixed in 4% buffered paraformaldehyde solution and decalcified using EDTA. Samples were embedded in paraffin and 4 μm sections were prepared. For immuno histochemical analysis, sections were deparafinised in xylene and rehydrated from graded ethanol to water. Endogenous peroxidase activity was blocked using 0.3% hydrogen peroxide in methanol (15 min 
Histology
4 µm sections were used after fixation and decalcification as described above. Sections were deparafinised in xylene and rehydrated from graded ethanol (100%-96%-70%) to distilled water.
For morphogenetic analysis, sections were stained in hematoxylin and eosin (H&E).
RNA isolation and qPCR
After collecting samples, tissues were snap frozen in liquid nitrogen and stored at -80 ºC until further analysis. Before RNA isolation, samples were crushed with pestle and mortar on liquid nitrogen. To isolate total RNA, crushed samples were incubated in Trizol and were beaten with glass beads thrice for 10 s with a mini-beadbeater (Biospec Products, Bartlesville, OK, USA).
Afterwards, RNA was precipitated using isopropanol and centrifugation ( segmented into woven bone (low degree of mineralization; 14.5-36% of maximal image gray value) and lamellar bone (high degree of mineralization >36%). Based on the described gray values, the degree of mineralization could be quantified [18] .
Radiologic analysis
Four regions of interest were described. The first was the total region (TOT) and was defined as The regions of interest are represented schematically in figure 6A .
After placement of the plate-screw osteosynthesis and after euthanasia, lateral X-rays (40 kV, 12.5 mAs, Esotron HF50, E. Schweizer AG, Switzerland) were made for evaluation of plate and screw placement and bridging of the osteotomy gap. Bridging of the gap and thus nonunion development was scored by two independent, blinded, and experienced co-workers.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5 (GraphPad, San Diego, California, USA). Normality was checked using the Shapiro-Wilks test. The data are represented as means and standard error of the mean (SEM). Significance was tested using ANOVA with post hoc Bonferroni correction. P-values below 0.05 were considered statistical significant.
3.
RESULTS
Increased plasma amino acid concentrations in Nos3 deficient mice
No differences were present in systemic concentrations of arginine, citrulline and ornithine between wild type mice and both nitric oxide synthase deficient groups in plasma samples obtained after 7 days of fracture healing (Figure 2A, 2B and 2C ).
After 28 days of fracture healing, plasma concentrations of all amino acids were significantly enhanced in Nos3 -/mice compared with wild type animals (arginine: p < 0.001; Figure 2A , citrulline: p < 0.0001; Figure 2B , ornithine: p < 0.05; Figure 2C ). Arginine (p < 0.05; Figure 2A) and citrulline (p < 0.0001; Figure 2B ) concentrations of Nos3 -/mice also showed significant higher concentrations when compared with Nos2 -/animals. Measured citrulline levels showed a distinct decrease (p < 0.01) in Nos2 -/mice between samples measured at 7 and 28 days of follow-up, whereas in Nos3 -/animals these concentrations were enhanced (p < 0.05).
The arginine availability in plasma, defined by the ratio between the arginine concentration and the combined ornithine and lysine concentration decreased over time between samples obtained after 7 and 28 days of fracture healing in Nos2 -/and Nos3 -/animals ( Figure 2D ).
Decreased amino acid concentrations in NOS2 and NOS3 deficient callus tissue
Amino acid concentrations in femur tissue were measured in fractured bones and contralateral unfractured control bones. Arginine concentrations measured in callus tissue showed no differences between the different mouse strains at both time points ( Figure 3A ).
After 28 days of fracture healing, callus tissue from wild type mice showed significant higher citrulline concentrations when compared to callus tissue from 7 days of fracture healing (p < 0.05; Figure 3B ). Also, Nos2 -/mice had significantly lower citrulline concentrations compared to wild type animals at 28 days (p < 0.01). Callus citrulline concentrations in Nos3 -/mice tended to be lower compared to wild type mice.
After 28 days of fracture repair, callus tissue of wild type and Nos3 -/mice showed ~1.5-2 fold lower ornithine concentrations when compared to callus tissue collected after 7 days (p < 0.001 and p < 0.05 respectively; Figure 3C ).
Fractured femurs in wild type mice after 28 days showed significant lower ornithine concentrations when compared with Nos2 -/mice (p < 0.05). Fractured femurs of Nos2 -/as well as Nos3 -/mice showed significantly higher ornithine concentrations when compared with their contralateral non-fractured femurs after 7 days of fracture healing (p < 0.05 and p < 0.01 respectively, figure 3C ). The decrease of ornithine concentrations over time as visible in fractured femurs was not present in unfractured controls.
Callus tissue of wild type animals after 28 days of fracture healing showed significantly higher arginine availability ( Figure 3D ) when compared with both Nos2 -/-(p < 0.001) and Nos3 -/-(p < 0.05) mice. The tissue arginine availability index increased between 7 and 28 days of follow-up in both wild type mice (p < 0.0001) and Nos3 -/mice (p < 0.05), but not in Nos2 -/mice.
Elevated myeloperoxidase influx in callus tissue of Nos2 -/and Nos3 -/mice
Femur samples of both Nos2 -/and Nos3 -/animals collected 28 days after the osteotomy procedure showed significantly elevated neutrophil influx (p < 0.05 and p < 0.01 respectively; Figure 4A and B) as measured by MPO levels in the callus region and the proximal and distal marrow cavities when compared to wild type mice. Nos3 -/mice regained a normal level of MPO influx after 42 days of fracture healing, whereas Nos2 -/animals still showed a high degree of MPO influx (p < 0.01 when compared with wild type animals). Figure 4C shows H&E staining results of fractured femurs after 42 days of follow-up. Wild type animals presented with callus formation between the proximal and distal fracture parts, whereas in both Nos2 -/and Nos3 -/mice, no evident callus formation was visible.
Upregulation of arginase-1 RNA in callus tissue
Contralateral unfractured control femurs showed no Arginase-1 expression after both 7 and 28 days of follow-up ( Figure 5A ), while all fractured femurs presented detectable levels of Arginase-1. In addition, in all mice, Arginase-1 showed a 2-fold lower concentration at 28 days compared to 7 days. Furthermore, at 28 days Nos3 -/mice had a significantly lower Arginase-1 expression compared to Nos2 -/mice (p < 0.05).
Nos2 and Nos3 expression
Nos2 mRNA expression was lower in the fractured femur at 7 days compared to the normal femur, while at 28 days the reverse was present. While Nos2 expression was absent in Nos2 -/mice, Nos2 expression in Nos3 -/mice was higher at 28 days ( Figure 5B , p < 0.05).
Nos3 expression in wild type animals remained similar in fractured femur tissue at 7 and 28 days compared to non-fractured femurs. Nos3 expression at 28 days tended to be increased in Nos2 -/mice compared to wild type and Nos3 -/mice ( Figure 5C ).
Evident nonunion development in Nos2 -/and Nos3 -/on micro-computed tomography
In figure 6B -G, qualitative images of representative micro-CT measurements are shown of femurs after 28 and 42 days of fracture repair in wild type mice, and Nos2 -/and Nos3 -/mice. Grey structures indicate mineralized bone and green structures indicate newly formed callus tissue.
Both strains of knock out mice showed almost no signs of bone formation at both time points.
Micro-CT measurements of total callus volume showed higher volumes in wild type mice when compared to both Nos2 -/and Nos3 -/animals ( Figure 6H ) after 28 and 42 days of fracture healing (p < 0.05). Periosteal callus volume ( Figure 6I ) was significantly lower in Nos2 -/mice when compared with wild types (p < 0.05) after 28 days of fracture healing. Endosteal callus volumes were significantly lower in Nos3 -/mice after 28 days of fracture healing ( Figure 6J , p < 0.05).
After 42 days of fracture healing, Nos2 -/and Nos3 -/animals both showed lower periosteal and endosteal callus volumes in comparison with wild type mice (p < 0.05).
In the GAP region between the proximal and distal part of the femur, ~3-4 fold lower callus volumes were observed in both nitric oxide synthase deficient strains when compared to wild type mice after 28 and 42 days of fracture healing. However, due to the large variation in the quantified results, differences did not reach a level of significance ( figure 6K) .
After scoring the X-rays and micro-CT images of animals euthanized after 42 days, wild type mice showed in 9 out of 9 animals bridging of the osteotomy gap. In Nos2 -/mice, 1 of 9 animals showed bridging, and no animals with a Nos3 -/background had sufficient callus formation. Figure   7 shows representative X-ray images of the mice right after placement of the plate-screw osteosynthesis and after 42 days of fracture healing.
4.
DISCUSSION
In the present study we show that both the absence of either endothelial or inducible nitric oxide synthase results in an inadequate fracture healing, as demonstrated by the transition of a delayed union into a nonunion in mice after femur osteotomy with periosteal cauterization. Both Nos2 During normal conditions, the process of bone healing in mice until there is no interfragmentary motion takes around three weeks [22] . In our study, we cauterized the periosteum to create a clinically relevant situation of compromised fracture healing. This cauterization delayed the fracture healing in wild type animals by approximately one week (data not shown).
As far as our knowledge extends, our study is the first to measure callus volume in both Nos2 and Nos3 knockout animals in comparison with wild type animals during different time points in the fracture healing process. Micro-CT is an ideal method to not only quantify tissue volumes but also to differentiate it spatially. We were able to show that Nos2 -/and Nos3 -/mice had significantly lower quantities of total callus volume, and thus the important influence of these enzymes on fracture healing. Whereas in Nos2 -/animals periosteal callus formation was hampered after 28 days of fracture healing, Nos3 -/mice showed significantly lower endosteal callus volume, suggesting different pathways in which fracture healing is disturbed in these animals.
Diwan et al and Zhu et al both showed a temporal [13] and localized [14] increased expression of NOS isoforms, compared to the normal unfractured femoral cortex [12] , during the normal healing process of femoral fractures in rodents. In their studies, NOS2 was primarily present during the initial inflammatory stage and mainly found within the intramembranous region, along the edge of the periosteal callus. NOS3 is present during the secondary bone formation in cells in the chondral region and lining of blood vessels.
In our study, a decrease in Nos2 expression in the callus tissue after 7 days of delayed fracture healing was present in wild type animals compared to normal non-fractured femurs, while the opposite occurred after 28 days. In a study by Corbett et al [23] levels of NOS2 protein displayed a similar pattern at 7 and 28 days of fracture healing. Thus, while in normal fracture healing NOS2 activity is upregulated, delayed fracture healing coincides with a decreased expression of NOS2 compared to normal bone. Indeed, with complete deletion of the NOS2 expression we demonstrate that bone healing is further compromised and nonunion occurs. This relationship is further emphasized in studies were suppression of NO synthesis by feeding rats orally with the non-selective NOS inhibitor L-nitroso-arginine methyl ester (L-NAME) resulted in a decrease of callus cross-sectional area and maximum failure load during three-point-bending tests [12] .
Fractured femurs of Nos2 knockout mice are known to have a decreased maximum energy absorption and torsional failure during strength testing [24] . Biomechanical properties of unfractured Nos2 knockout femurs showed no differences when compared to those of wild type mice. These data emphasize the importance of NOS2 in fracture healing.
Our results demonstrate that in the absence of NOS3, fracture healing is hampered with decreased callus formation and nonunion development. Previously, an increased expression of NOS3 was shown in cortical blood vessels during fracture repair, which mediates an increased blood flow during normal fracture repair [23] . An experimental model of normal fracture healing in rats showed changes in local vascular reactivity at the fracture site after intravenous pharmacological stimulation or inhibition of NO during initial phases of fracture healing [6] . NOS3
is known to play a key role in postnatal regulation of bone mass, as young Nos3 knockout mice show a reduced bone volume and defects in osteoblast differentiation, maturation and activity and reduced rates of growth factors [25, 26] . These data suggest the importance of NOS3 in the later bone formation phases.
As previously reported, the inflammatory response plays an important role in normal fracture healing [1, 27] . In our study, we showed a higher level of MPO in callus tissue and proximal and distal marrow cavities in the femur of both Nos2 -/and Nos3 -/animals at 28 days, while it continued to be increased until 42 days in the Nos2 -/mice fracture callus. Nos2 expression is known to be drastically increased on RNA and protein levels in osteoblasts and bone marrow macrophages during inflammatory conditions [28] . In addition, Watanuki et al demonstrated inadequate response of bone and bone marrow cells to reloading of unloaded NOS2 deficient murine tibiae [29] .
In this study, we have not looked into the role of NOS1 during the follow-up period. NOS1 is mainly up-regulated in the later stages of fracture healing [13] (i.e. bone remodeling), hence after callus formation. The fact that nonunion development depends on disturbances during the inflammatory phase and subsequent callus formation [30, 31] led us to focus on NOS2 and NOS3 which is generally expressed during the primary phases of bone healing.
In a previous study, our group already showed that disturbed amino acids concentrations were associated with nonunion development in humans [11] . In atrophic nonunions, concentrations of arginine, citrulline and ornithine were significantly lower in comparison with healthy controls. To determine the role of the substrate availability (arginine and citrulline) on delayed union and nonunion development in this model, these amino acid concentrations were measured. As observed, the arginine availability was significantly decreased after 28 days of fracture healing in Nos2 -/and Nos3 -/animals, which indicates the importance of NOS presence and arginine availability on fracture healing.
In this study, arginine availability was significantly decreased. Kdolsky et al were the first to report a possible influence of oral L-arginine supplementation to be beneficial on fracture healing in an in vivo study in guinea pigs [32] with signs of improved fracture healing on radiographic imaging.
Based on these findings and this study, we hypothesize that stimulation of the arginine-NO metabolism might be a promising possible therapeutic option in decreasing the percentage of nonunion and delayed union development after fractures. Further research into amino acids associated with the arginine-NO metabolism is needed to elucidate these possibilities in bone anabolism and catabolism. In muscle tissue it is known that in patients who are immobilized due to long term hospital admission and immobility, anabolic reactions in muscles are diminished whereas catabolism is enhanced.
In conclusion, this study shows that a disturbed arginine-NO metabolism by blocking inducible or endothelial NOS facilitates the development of nonunion in a delayed union mouse model.
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